8-K current report · filed Nov 4, 2026

Xencor Inc (XNCR) 8-K Current Report: November 4, 2026

Item 2.02Item EX-99.1XNCR overview

Short answer

Xencor Inc (XNCR) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results for quarter ended September 30, 2026.

Xencor Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results for quarter ended September 30, 2026
  • Press release containing results attached as Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $116.5M vs $21.0M, driven by Alexion and Incyte royalties plus Astellas milestone revenue
  • Net income $39.4M, or $0.50 diluted EPS, versus $6.0M loss and $(0.08) EPS in Q3 2025
  • XmAb819 showed 45.5% confirmed response rate at 400 mcg/kg IV in advanced ccRCC, supporting potential Phase 3 development
  • XmAb819 regulatory engagement planned for 1H27, with potential global randomized Phase 3 initiation by end-2027
  • Cash and marketable debt securities $555.7M, with $480M-$500M expected year-end cash and funding projected into 2029

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Xencor Inc 8-K filings

Get the next XNCR 8-K as it lands

Follow XNCR for push alerts, or ask the research agent what this filing means.